Today's Date: October 2, 2023
EPA Names Clorox as 2023 Safer Choice Partner of the Year for Advancing Ingredient and Product Safety   •   Carmen M. Hernández Joins HITN’s Board of Directors   •   ComplyCube Unveils No-ID Age Estimation to Address Growing Global Age-Restriction Regulations   •   Remedios Varo Exhibition at Art Institute of Chicago Celebrates Hispanic Heritage Through Art   •   Veteran Tech Exec Sissie Hsiao joins Bumble Inc. Board of Directors   •   Link Logistics Publishes Third Annual ESG Report   •   Global Gaming Women Announces Event Line-up at Global Gaming Expo 2023 including the 13th Annual Kick Up Your Heels Fundraiser   •   Simon® Earns GRESB Green Star   •   Most Women Skipping Annual Mammograms, According to New MedStar Health Survey   •   Afya Limited to Report Third Quarter and Nine Months 2023 Financial Results on November 13th   •   BWX Technologies to Announce Third Quarter 2023 Results on Wednesday, November 1   •   Feinstein Institutes’ Ross Prize awardees win 2023 Nobel Prize in Physiology or Medicine   •   U.S. Postal Service Commemorates Legacy of Ruth Bader Ginsburg   •   Essential Utilities Completes Sale of West Virginia Gas Utility Assets   •   iQor Celebrates Customer Service Week 2023   •   Andreozzi + Foote File Lawsuits as the New Maryland Child Victims Law Takes Effect   •   Honouliuli National Historic Site Commemorated with Blessing Event and Plaque Dedication Ceremony   •   Empire State Realty Trust Announces Acquisition of Prime Retail Asset in Williamsburg, Brooklyn, as Part of Capital Recycling Pr   •   J&J Patent Move Must be First of Many, says AHF   •   How to Make a Difference This Halloween
Bookmark and Share

Precision BioSciences to Present at Upcoming June Investor Conferences

DURHAM, N.C. , June 05 /Businesswire/ - Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage gene editing company developing ARCUS®-based in vivo gene editing and ex vivo allogeneic CAR T therapies, today announced that members of management will participate in the following investor conferences in June 2023:

Jefferies Global Healthcare Conference 2023

Date: Friday, June 9, 2023

Time: 10:30 am ET

Goldman Sachs 44th Annual Global Healthcare Conference

Date: Thursday, June 15, 2023

Time: 8:40 am PT (11:40 am ET)

A live webcast of each presentation will be accessible on the Company’s website www.precisionbiosciences.com, under the Investors & Media section. An archived replay of the webcasts will be available for approximately 30 days following each event.

About Precision BioSciences, Inc.

Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly precise and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of several in vivo gene editing candidates designed to cure genetic and infectious diseases where no adequate treatments exist and multiple ex vivo clinical candidates. For more information about Precision BioSciences, please visit www.precisionbiosciences.com.


STORY TAGS: Webcast, Trade Show, Conference, Health, Genetics, Other Science, Research, Science, Pharmaceutical, Biotechnology, United States, North America, North Carolina,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News